Over the last three decades, autoimmunity against MBP, PLP, and more recently also against other CNS myelin proteins, such as MOG, MOBP and OSP, has been extensively investigated in MS patients, HLA class-II Tg mice, and in wild-type mice, as major target antigens in MS. Here, MOG is linked to myeloid sarcoma.